Biliary Tract Carcinoma
📧 Sign up to get email alerts when something new happens for Biliary Tract Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer [Phase 2]
A Phase 2 trial sponsored by Mayo Clinic compares at-home cancer-directed therapy to in-clinic treatment for patients with various advanced …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating olanzapine for cancer-associated appetite loss in patients with advanced esophageal, gastric, colorec…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma [Phase 2]
A Phase 2 clinical trial update evaluating GEMOX (gemcitabine + oxaliplatin) in combination with donafenib and tislelizumab for advanced bil…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating ZG005 in combination with platinum-based chemotherapy for advanced biliary tract carcinoma, with the stu…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. [NA]
A multicenter Phase II basket trial at Zhejiang Cancer Hospital is evaluating hypofractionated radiotherapy or SBRT followed by immunotherap…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma [Phase 2]
This is a Phase 2 clinical trial evaluating irinotecan hydrochloride liposome in combination with capecitabine as second-line therapy for ad…